Financial Disclosure

Stockholm – October 12, 2026 -- Sandvik lifted second-quarter adjusted EBITA to SEK 8,306 million from SEK 5,629 million a year earlier, with the adjusted EBITA margin widening to 22.6% from 19.0%.

Revenues rise 24% at fixed exchange rates

Revenues reached SEK 36,752 million, up from SEK 29,700 million in the prior-year quarter. At fixed exchange rates, revenue growth was 24%, of which 23% was organic.

Order intake totaled SEK 37,799 million, against SEK 32,206 million a year earlier. At fixed exchange rates it grew 17%, and organic growth was also 17%.

Adjusted EBIT margin expands to 21.4%

Adjusted EBIT rose to SEK 7,855 million from SEK 5,194 million, lifting the margin to 21.4% from 17.5%. Adjusted profit before tax came in at SEK 7,601 million, compared with SEK 4,855 million.

Stockholm – October 12, 2026 -- Sandvik has secured an underground mining equipment order worth around SEK 275 million from Kamoa Copper S.A. for the Kamoa-Kakula copper mine in the Democratic Republic of the Congo.

Sandvik will book the SEK 275 million order in the third quarter of 2026

The package includes trucks and loaders. Two of the loaders will be equipped with AutoMine®, Sandvik's automation solution.

Deliveries to Kamoa-Kakula run from Q4 2026 through Q3 2027

Shipments are scheduled to begin in the fourth quarter of 2026 and continue through the third quarter of 2027, a delivery window of roughly one year.

Kamoa-Kakula is a long-life, high-grade underground copper operation. Sandvik machines have operated at the site since 2019, making this a repeat selection by the customer.

Toronto – October 12, 2026 -- Profound Medical Corp. (NASDAQ: PROF; TSX: PRN) will report its second quarter 2026 financial results after market close on Thursday, August 6, 2026.

Management hosts call at 4:30 p.m. ET on results day

The interventional MRI (iMRI) company will hold a conference call at 4:30 p.m. ET on August 6 to review the quarter's results and discuss business developments in the period. Investors must register in advance for the live call.

Two MRI-guided platforms drive the commercial portfolio

Profound markets TULSA-PRO, which is FDA-cleared in the United States for transurethral ultrasound ablation (TULSA) of prostate tissue. The system is also cleared in Europe, Canada, Saudi Arabia, India, Australia/New Zealand and the UAE.

Toronto – October 12, 2026 -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) cut its second-quarter 2026 net loss 39% to about $9.5 million, or $0.26 per share, from $15.7 million, or $0.52 per share, a year earlier. Operating expenses fell 16% to about $13.0 million, and the company reiterated its full-year revenue guidance of about $25.0 million.

Shipment delay pushes $3.1 million of TULSA revenue into July

Q2 revenue was about $2.5 million, up 12% year over year. Recurring non-capital revenue from single-use devices and extended-warranty services contributed $1.6 million, and capital equipment sales added $871,000.

About $3.1 million of TULSA product shipments expected in the final week of June went out in July and will be recognized in Q3. Excluding the delay, Q2 revenue would have been about $5.6 million, or 153% growth. The company attributes the slip to a logistics issue, not weaker demand, and says the issue is resolved.

Toronto – October 12, 2026 -- Profound Medical Corp. expects third-quarter 2026 revenue of $9.8 million to $10.0 million, roughly 45% to 47% above the Bloomberg mean analyst consensus of $6.78 million.

Revenue nearly doubles year over year and almost quadruples sequentially

The preliminary, unaudited range implies growth of approximately 85% to 89% from $5.3 million in the third quarter of 2025. Compared with $2.5 million in the second quarter of 2026, revenue is expected to rise approximately 292% to 300%.

The Nasdaq- and TSX-listed company expects gross margin to exceed 70% for the quarter, again above that threshold. Profound attributes the margin to progress in its commercial operations and scale.

Dublin – October 12, 2026 -- AerCap Holdings N.V. raised its full-year 2026 adjusted earnings per share guidance to approximately $16.80 after reporting second-quarter net income of $726 million, or $4.59 per share. Adjusted net income reached $811 million, or $5.14 per share. The guidance excludes any additional gains on sale for the rest of the year.

AerCap sells $1.4 billion of assets at a 20% unlevered gain margin

The lessor booked a net gain on sale of $223 million on 38 owned assets sold for $1.4 billion. A year earlier it recorded $57 million of gains on 18 assets sold for $374 million. The second-quarter sales equate to 1.7x book value on an equity basis.

Return on equity was 16% for the quarter, or 18% on an adjusted basis. Operating cash flow totaled $1.5 billion.

DUBLIN – October 12, 2026 -- AerCap Holdings N.V. (NYSE: AER) has filed its interim financial report for the quarter ended June 30, 2026, with the U.S. Securities and Exchange Commission, including unaudited condensed consolidated financial statements and notes.

AerCap submits the second-quarter filing on Form 6-K

The report was filed as a Form 6-K. It is available in the Investors section of AerCap's website and on the SEC's website. The announcement itself contained no revenue, earnings or fleet figures; those details sit in the filing.

AerCap lists sanctions, tariffs and rates among the risks to its results

The company's forward-looking statements name the continued impact of the Ukraine conflict as a risk, including sanctions imposed by the United States, the European Union, the United Kingdom and other countries. They also cite hostilities in the Middle East and any escalation of them.

Dublin – October 12, 2026 -- AerCap Funding Designated Activity Company, a wholly-owned subsidiary of AerCap Holdings N.V., has priced $1.5 billion of senior notes split evenly between a 2030 and a 2033 maturity.

AerCap Funding splits the $1.5 billion offering into two $750 million tranches

The 5.500% Senior Notes due 2030 and the 5.875% Senior Notes due 2033 each carry a principal amount of $750 million. The 2033 tranche pays a coupon 0.375 percentage points higher than the 2030 tranche in exchange for three additional years of maturity.

AerCap Holdings and certain other subsidiaries will guarantee the notes fully and unconditionally on a senior unsecured basis.

Dublin – October 12, 2026 -- AerCap Holdings N.V. (NYSE: AER) completed 204 asset transactions in the third quarter of 2026 and returned about $783 million to shareholders through a share repurchase of 5.3 million shares at an average price of $147.12.

AerCap signs 85 leases across aircraft, engines and helicopters

The lessor signed 85 lease agreements in the quarter: 16 widebody aircraft, 45 narrowbody aircraft, 13 engines and 11 helicopters. It also signed financing transactions worth approximately $900 million.

AerCap buys 32 aircraft, led by 20 Boeing 737 MAX jets

AerCap completed 34 purchases covering 32 aircraft and 2 helicopters. The aircraft bought for its owned portfolio were 20 Boeing 737 MAX, 8 Airbus A320neo Family, 2 Boeing 787-9s and 2 Embraer E195-E2s.

Columbus – October 12, 2026 -- American Electric Power (Nasdaq: AEP) has launched a registered underwritten offering of $2.6 billion of common stock, structured around forward sale agreements with three banks.

BofA, Goldman Sachs and Morgan Stanley lead the underwriting

BofA Securities, Goldman Sachs & Co. LLC and Morgan Stanley are acting as joint book-running managers. Subject to certain conditions, the forward counterparties or their affiliates are expected to borrow all shares from third parties and sell them to the underwriters.